Frankfurt - Delayed Quote EUR
Heron Therapeutics, Inc. (AXD2.F)
1.9010
+0.0260
+(1.39%)
As of 8:04:42 AM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
233,147
222,506
250,951
305,706
Total Liabilities Net Minority Interest
266,798
256,479
237,379
228,136
Total Equity Gross Minority Interest
-33,651
-33,973
13,572
77,570
Total Capitalization
141,075
139,780
162,856
226,652
Common Stock Equity
-33,651
-33,973
13,572
77,570
Capital Lease Obligations
3,037
5,875
8,193
10,413
Net Tangible Assets
-33,651
-33,973
13,572
77,570
Working Capital
117,557
109,089
123,080
183,365
Invested Capital
141,075
139,780
162,856
226,652
Tangible Book Value
-33,651
-33,973
13,572
77,570
Total Debt
177,763
179,628
157,477
159,495
Net Debt
148,924
145,076
133,920
58,541
Share Issued
152,094.9120
150,285.0440
119,155
102,005
Ordinary Shares Number
152,094.9120
150,285.0440
119,155
102,005
12/31/2021 - 5/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
12X1.F Anavex Life Sciences Corp.
8.05
-0.96%
HTD.SG Corcept Therapeutics Inc
62.34
+0.94%
M8W.F MediWound Ltd.
15.60
+0.65%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
REGN34.SA Regeneron Pharmaceuticals, Inc.
56.05
+0.59%
REGN.VI Regeneron Pharmaceuticals, Inc.
519.40
-0.08%
PYPD PolyPid Ltd.
2.7100
-1.45%
BVNRY Bavarian Nordic A/S
7.72
0.00%
SNGX Soligenix, Inc.
2.1309
+2.94%
XFOR X4 Pharmaceuticals, Inc.
0.1853
-7.95%